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Discussion Paper
Uptake in cancer screening programmes: a priority in cancer
control
DP Weller*,1 and C Campbell1
1Division of Community Health Sciences – General Practice, University of Edinburgh, 20 West Richmond St, Edinburgh EH8 9DX, UK
Achieving adequate levels of uptake in cancer screening requires a variety of approaches that need to be shaped by the characteristics
of both the screening programme and the target population. Strategies to improve uptake typically produce only incremental
increases. Accordingly, approaches that combine behavioural, organisational and other strategies are most likely to succeed. In
conjunction with a focus on uptake, providers of screening services need to promote informed decision making among invitees.
Addressing inequalities in uptake must remain a priority for screening programmes. Evidence informing strategies targeting
low-uptake groups is scarce, and more research is needed in this area. Cancer screening has the potential to make a major
contribution to early diagnosis initiatives in the United Kingdom, and will best be achieved through uptake strategies that emphasise
wide coverage, informed choice and equitable distribution of cancer screening services.
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Cancer screening is an important element of any national
strategy to improve early cancer diagnosis. The NAEDI initiative
(Department of Health NAEDI Newsletter, 2009) emphasises a
multi-faceted approach; there is a need to raise awareness of
cancer symptoms and make health services better equipped to
respond to symptoms. In parallel, effective and efficient cancer
screening programmes based on sound evidence are needed.
Indeed, cancer screening can effectively complement awareness
and early diagnosis initiatives; a screening programme can, for
example, raise awareness in the community of particular cancers
and their associated symptoms.
Uptake (i.e. the proportion of screening invitees in a given year
for whom a screening test result is recorded) is the most important
factor in determining the success of a screening programme
(Barratt et al, 2002; Parkin et al, 2008). The United Kingdom
has, over recent decades, taken an organised, population-wide
approach to screening; although the exact contribution of cancer
screening to an observed reduction in mortality in the population
can be difficult to quantify, modelling exercises suggest that cancer
screening activity over recent decades has made a significant
difference (Blanks et al, 2000; Raffle et al, 2003; Taylor et al, 2004;
van der Aa et al, 2008). However, mortality reductions are brought
about by many contributory factors and therefore combined
approaches that include earlier presentation, more timely diag-
nosis and improved treatments are considered to hold the greatest
promise of improved cancer outcomes (Department of Health NHS
Cancer Plan, 2000).
Experience in the United Kingdom suggests that achieving and
maintaining uptake in cancer screening requires ongoing effort;
coverage (i.e. the proportion of resident and eligible individuals
who have had a test with a recorded result in a screening round)
can decline from one round of screening to the next, and the
causes of this drop-off are often difficult to identify (Weller et al,
2007; Lancuck et al, 2008). A number of systematic reviews have
examined the evidence supporting various approaches to cancer
screening uptake (Jepson et al, 2000; Bonfill et al, 2001; Forbes
et al, 2002). The findings typically vary according to factors such as
cancer site, type of test and target population. However, organised
recruitment strategies (the approach typically taken in the United
Kingdom, which involves systematic recruitment and follow-up,
the provision of scheduled appointments for screening), and
personalised invitation approaches (for example, from a general
practitioner) seem to show consistent benefits over opportunistic
approaches to screening. Reducing structural barriers to accessing
services (e.g. location, timing of appointments, childcare facilities)
can also increase uptake (Baron et al, 2008).
It is timely, in this BJC issue, to examine the main predictors of
uptake for the United Kingdom’s three established cancer screen-
ing programmes (breast, cervical and colorectal screening), along
with the evidence supporting strategies to improve uptake in each
of these programmes.
CERVICAL SCREENING
Variations in uptake
Recently, declining rates in cervical screening, particularly in
younger women, have prompted renewed interest in the issue of
adequate, population-wide coverage (Lancuck et al, 2008). Women
from ethnic minorities and deprived sub-groups in the population
have shown consistently lower uptake over decades of screening
in countries worldwide (Webb et al, 2004; Moser et al, 2009) –
particularly among groups born outside their host country (Downs
et al, 2008). Health literacy is also an important determinant; the
messages in cervical cancer screening recruitment materials are
relatively complex, and strategies targeting invitees with limited*Correspondence: Dr DP Weller; E-mail: david.weller@ed.ac.uk
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health literacy require careful design and, ideally, flexibility in
recruitment procedures (Giordano et al, 2008).
Strategies to improve uptake
While setting recruitment targets in UK primary care can lead to
improved uptake, even in deprived populations (Baker and
Middleton, 2003), interventions of proven sustainable benefit are
typically multi-faceted, and result from efforts to make the
approaches to target groups socially and culturally appropriate
(Dietrich et al, 2006; Tu et al, 2006). The media has an important
role to play in cervical screening through, for example, programme
story-lines where a character has cancer (Meissner et al, 2004) in
the United Kingdom this can produce profound short-term effects,
although evidence for effectiveness in bringing about sustained
increases is variable (Howe et al, 2002).
On-going effort, particularly targeting ethnic sub-groups, seems
justified in the United Kingdom, although an ‘off-the-shelf’
strategy remains elusive. Ideally, detailed socio-demographic and
ethnic information should be available at local levels, to tailor
strategies with local effect. The advent of HPV vaccination
introduces a new dynamic into cervical screening uptake, and
this will require further refinement of messages promoting uptake
of screening over the next several years.
BREAST SCREENING
Variations in uptake
Socio-economic status is a powerful driver of uptake in breast
screening, as shown in the recent National Statistics Omnibus
Survey (Moser et al, 2009). Importantly, deprived populations seem
to have later stage presentation in breast cancer-compounding the
potential effects of inequalities of breast screening uptake
(Cuthbertson et al, 2009). There is compelling evidence that certain
ethnic sub-groups in the United Kingdom have lower participation
rates than the general population (Szczepura et al, 2008).
Strategies to improve uptake
In common with other forms of screening, individuals vary in their
response to a breast screening invitation; factors such as perceived
risk of cancer and perceived ability to undertake the test are
important, and interventions should ideally incorporate theoretical
psychological models (Champion et al, 2007). Endorsement of
breast screening from primary care seems to have a consistent,
albeit modest, effect on recruitment (Bankhead et al, 2001).
Research on targeting low-uptake groups has typically used
customised approaches and, on balance, shows a beneficial effect
– for example, strategies such as tailored telephone counselling
seem to improve uptake (Luckmann et al, 2003). We should,
however, be cautious about attempting more intense recruitment
strategies across different regions of the United Kingdom – again,
there is no one strategy with proven benefit in different contexts.
While strategies such as phone calls and home visits can produce
modest increases in breast cancer screening uptake, these efforts
are labour intensive and may not be cost-effective on a population-
wide scale in the United Kingdom (Kearins et al, 2009).
COLORECTAL SCREENING
Variations in uptake
Colorectal screening, using the FOBT, is now being ‘rolled out’ in
all four countries of the United Kingdom. There is already
compelling evidence that certain ethnic sub-groups in the United
Kingdom have lower participation rates of colorectal screening
than the general population – this applies to screening using both
FOBT and flexible sigmoidoscopy (Robb et al, 2008; Szczepura
et al, 2008). The reasons for these differences are complex,
underpinned by a range of health beliefs and cultural attitudes; in
some ethnic sub-groups participation in screening is at odds with
cultural norms, and issues such as perceived lack of self-efficacy,
cultural misunderstandings, barriers relating to spiritual beliefs
and fear of cancer are all significant. Further, profound differences
in uptake rates between socio-economic groups have emerged in
countries adopting screening (Weller et al, 2007; Deutekom et al,
2009).
Colorectal screening is targeted at both males and females,
and there is some evidence that males and younger age groups
have lower uptake rates of FOBT screening (Weller et al, 2007;
Pornet et al, 2009). However, the evidence is less clear for
endoscopic procedures such as colonoscopy or flexible sigmoido-
scopy (UK Flexible Sigmoidoscopy Screening Trial, 2002; Meissner
et al, 2006). Men appear to have higher rates of participation,
although there are exceptions, such as a recent population-based
trial of flexible sigmoidoscopy screening from Norway (Hoff et al,
2009).
Again, literacy is a critical determinant of participation in
colorectal cancer screening. A great deal of effort has been devoted
to producing information and materials for the bowel cancer
screening programmes, which are comprehensive, informative and
balanced – yet we know that health literacy varies a great deal in
the population (von Wagner et al, 2009b), and many invitees will
have limited comprehension of recruitment materials.
Strategies to improve uptake
Again, interventions of proven benefit targeting deprived and
ethnic sub-groups are typically multi-faceted, and result from
efforts to make the approaches to target groups socially and
culturally appropriate (Tu et al, 2006). The type of test used is also
important. On the whole, tests that are simpler and which
minimise factors such as cost, inconvenience and distaste
(e.g. from handling faeces in faecal occult blood testing), are
associated with greater uptake (Federici et al, 2005). Endorsement
of cancer screening from primary care can improve uptake
although, again, the effect is quite modest (Federici et al, 2006);
evidence from the United States suggests that engagement of wider
primary care teams is particularly promising (Hudson et al, 2007;
Klabunde et al, 2007). Low primary care use has been associated
with a lack of CRC screening among both women and men
(Fenton et al, 2009).
As the current programme is implemented screening providers
need to avoid the possibility of patterns of low uptake in ethnic
and deprived groups becoming entrenched. We have the
opportunity with a new programme to trial new, tailored and
culturally appropriate approaches to these groups, and there is
currently a great deal of research activity and innovation in this
area. It is less clear whether specific effort should be directed at
males as the differences in uptake are not large and appear to be
less consistent in different regions of the United Kingdom.
Nevertheless, methods of approach, which accommodate male
perspectives and attitudes towards preventive health services,
should be considered – these may differ considerably from those of
women (Cullati et al, 2009), and require specific strategies to
overcome gender-specific barriers to screening uptake.
The timing of invitations may also be worth considering –
although it would require a substantial re-arrangement of current
recruitment processes in the bowel screening programmes. It
seems timing can have a positive effect, if invitations coincide with
annual milestones such as birthdays and festivals (Hoff and
Bretthauer, 2008). We so far have limited evidence supporting the
use of web-based resources in promoting CRC screening in the
United Kingdom, although US evidence suggests these approaches
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show promise, particularly, if they have a strong interactive
component (Ruffin et al, 2007).
SUMMARY
While other factors are important, ethnicity, social deprivation and
gender are the major determinants of cancer screening uptake in
United Kingdom cancer screening programmes – their effect on
uptake is summarised in Table 1. Strategies to improve cancer
screening uptake vary according to context, type of test and target
group – a summary of evidence is shown in Table 2. There is a
strong programme of research into cancer screening uptake in the
United Kingdom, and new evidence is emerging; in this British
Journal of Cancer supplement von Wagner et al (2009a) describe
socio-economic patterns of uptake for FOBT screening in London.
This adds to a growing body of literature showing that we need to
invest extra efforts in reducing inequalities in cancer screening
uptake. Further Eilbert et al (2009) provide an interesting model
for improving uptake – carefully tailored to local context in their
region of London, and involving multi-faceted approaches.
Increasingly, these are the kinds of approaches we will need to
improve uptake in an equitable way.
Ideally, the achievement of adequate uptake rates in cancer
screening should be accompanied by informed uptake – that is,
invitees should make informed choices and be aware of all the
risks and benefits of participation (Jepson et al, 2005). It is a
difficult concept to measure, and involves more than provision of
information – it includes a need to check understanding and to
explore decision making processes (Jepson et al, 2007; Woodrow
et al, 2008). Increasingly, individuals invited to screening are
encouraged to access and use more information to reach decisions
over participation (Welch, 2004).
CONCLUSIONS
The reduction in health inequalities is a major feature of the
Cancer Reform Strategy. Yet uptake of cancer screening is not
uniform across the population – within the United Kingdom, vari-
ation in uptake in cancer screening programmes is observed in
different population sub-groups: for both breast and cervical
screening uptake is lower in deprived communities and in some
black and ethnic minority communities; these same patterns are
seen in the more recently introduced bowel screening programme,
where gender has also been shown to affect participation.
Cancer screening uptake improvement strategies will continue
to require careful and creative design; socio-demographic and
cultural patterns of cancer screening uptake are well established,
and though strategies for improving uptake differ according to the
dynamics of the screening process, there are many generic lessons
that are transferable between the different screening programmes.
There is, for example, a small but growing body of evidence to
shape strategies targeting ethnic and deprived populations, and
both age- and gender-based sub-groups; however, there is a need
to develop a robust evidence base for effective interventions for
diverse populations within the United Kingdom.
Cancer screening should ideally work in tandem with other
awareness and early diagnosis initiatives. The NAEDI initiative is
part of a major push to further improve the United Kingdom’s
performance in cancer-related health outcomes (Department of
Health Cancer Reform Strategy, 2007); cancer screening pro-
grammes with good coverage, well-informed invitees and equitable
engagement of the population can have a major role.
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Table 1 Effect of deprivation, ethnicity and gender on uptake: examples from UK cancer screening programmesa
Breast Cervical Colorectal
Deprivation (range from most deprived to least deprived) 64–81%b 60–80% 37.2–61.2%c
Ethnicity (range from other/white) 51.7–77.3%d 37–75% 21.4–61.3%d
Gender N/A N/A 48% (M), 56% (F)c
aWhere figures are derived from published screening programme data, references are shown; otherwise figures are based on unpublished data and reports and represent an
estimate of contemporary rates across the United Kingdom. bInformation and Statistics Division Scotland http://www.isdscotland.org/isd/1623.html. cWeller et al, 2007; Steele
et al, 2009. dSzczepura et al, 2008.
Table 2 Summary of interventions with some evidence of effectiveness in cancer screening
Breast Cervical Colorectal
Deprived Lay worker/patient navigator
Telephone counselling
Tailored interventions (print and telephone)
Primary care endorsement
Workplace initiatives
Largely organisational approaches (in the United States)
Simpler tests
Telephone support
Patient navigators
Ethnic Translation services
Community-based interventions
(e.g. health educator
in a group setting)
Translation services
Lay workers
Psycho-educational counselling
Culturally sensitive materials
Home visits
Video and culturally sensitive educational materials
Telephone support
Gender N/A N/A Little available of proven effectiveness specifically
for men
Notes: The table is derived from ‘scoping’ the literature, not a systematic literature review. It includes information from many non-UK publications, therefore results may not be
directly transferable to UK contexts. There is considerable overlap between population sub-groups, so interventions targeted at one community often straddle for example both ethnicity
and deprivation. Not all studies are equally methodologically robust, and some have small numbers. The size of effect seen in these studies varies – some improvements were very
modest, and there is little evidence regarding how sustained their impact: interventions in the future will likely need to be multi-faceted and address attitudinal, language and cultural
concerns. There is a need for both additional systematic reviews in this area (focused on particular approaches and/or cancer type), and for new research studies in differing UK contexts.
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